The AJMC® Multiple Myeloma compendium is a comprehensive resource for clinical news and expert insights for this cancer.
Joseph Mikhael, MD, shares insights surrounding key updates in multiple myeloma management as presented at EHA 2024.
Balancing Cutting-Edge Therapies With Cost in Multiple Myeloma Treatment
Transforming Multiple Myeloma Care With Education and Advanced Therapies
MRD: A Game Changer in Multiple Myeloma
IMS 2024 Speakers Look Back on Exciting Myeloma Updates
Evaluating T-Cell Therapies in First-Line Multiple Myeloma Treatment
Creating Equitable AI Models for Multiple Myeloma
MRD as a New Paradigm in Myeloma Treatment
New CAR T Trial in MM Aims for Triple Receptor Targeting
Beyond EHA 2024: Promising Research in Multiple Myeloma to Watch
EHA 2024 Highlights: Overcoming Challenges with Bispecific Antibodies in RRMM
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Closing Gaps in CLL Care: Managed Care Insights and Strategies